161 related articles for article (PubMed ID: 12450231)
21. Management and 1-year outcomes of patients with atrial fibrillation in the Middle East: Gulf survey of atrial fibrillation events.
Zubaid M; Rashed WA; Alsheikh-Ali AA; Al-Zakwani I; AlMahmeed W; Shehab A; Sulaiman K; Qudaimi AA; Asaad N; Amin H;
Angiology; 2015 May; 66(5):464-71. PubMed ID: 24904179
[TBL] [Abstract][Full Text] [Related]
22. Selection of anticoagulants or antiplatelet-aggregating agents for prevention of stroke.
Kaplan ED; Sacco RL
Curr Neurol Neurosci Rep; 2002 Jan; 2(1):31-7. PubMed ID: 11898580
[TBL] [Abstract][Full Text] [Related]
23. Stroke prevention.
Sudlow C; Gubitz G; Sandercock P; Lip G
Clin Evid; 2002 Dec; (8):184-208. PubMed ID: 12603877
[No Abstract] [Full Text] [Related]
24. Transient ischaemic attacks and stroke.
Hankey GJ
Med J Aust; 2000 Apr; 172(8):394-400. PubMed ID: 10840494
[TBL] [Abstract][Full Text] [Related]
25. Transient ischemic attack: Part II. Risk factor modification and treatment.
Simmons BB; Gadegbeku AB; Cirignano B
Am Fam Physician; 2012 Sep; 86(6):527-32. PubMed ID: 23062044
[TBL] [Abstract][Full Text] [Related]
26. Secondary prevention of ischaemic stroke and TIA.
Diener HC
Cardiovasc J Afr; 2008; 19(4):229. PubMed ID: 18776974
[No Abstract] [Full Text] [Related]
27. [Antithrombotic therapy in ischemic stroke and transient ischemic attack].
Overgaard K; Poulsen TS; Husted SE
Ugeskr Laeger; 2007 Oct; 169(40):3379-82. PubMed ID: 17953858
[TBL] [Abstract][Full Text] [Related]
28. Current strategies of secondary prevention after a cerebrovascular event: the Vienna stroke registry.
Lalouschek W; Lang W; Müllner M;
Stroke; 2001 Dec; 32(12):2860-6. PubMed ID: 11739988
[TBL] [Abstract][Full Text] [Related]
29. Antiplatelet agents in stroke prevention: acute and long-term treatment strategies.
Weber R; Weimar C; Diener HC
Hamostaseologie; 2009 Nov; 29(4):326-33. PubMed ID: 19882077
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
[TBL] [Abstract][Full Text] [Related]
31. [Antithrombotic therapy in patients with first-ever stroke and known non-rheumatic atrial fibrillation].
Gandjour J; Zeindler J; Georgiadis D; Baumgartner RW
Praxis (Bern 1994); 2005 Jan; 94(4):97-104. PubMed ID: 15732803
[TBL] [Abstract][Full Text] [Related]
32. Secondary prevention of stroke.
MacWalter RS
Thromb Haemost; 1999 Sep; 82 Suppl 1():95-103. PubMed ID: 10695496
[TBL] [Abstract][Full Text] [Related]
33. Medical treatment in carotid artery intervention.
Kolkert JL; Meerwaldt R; Lefrandt JD; Geelkerken RH; Zeebregts CJ
J Cardiovasc Surg (Torino); 2011 Dec; 52(6):803-19. PubMed ID: 22051989
[TBL] [Abstract][Full Text] [Related]
34. Preventing stroke in patients with atrial fibrillation.
Edds W; Newton W
J Fam Pract; 2000 Jan; 49(1):8-9. PubMed ID: 10678330
[No Abstract] [Full Text] [Related]
35. Design and Rationale of the RELAXED (Recurrent Embolism Lessened by rivaroxaban, an Anti-Xa agent, of Early Dosing for acute ischemic stroke and transient ischemic attack with atrial fibrillation) Study.
Yasaka M; Minematsu K; Toyoda K; Yamagami H; Yoshimura S; Nagao T; Mori E; Hirano T; Hamasaki T; Yamaguchi T
J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1342-8. PubMed ID: 26987488
[TBL] [Abstract][Full Text] [Related]
36. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin.
Algra A; de Schryver EL; van Gijn J; Kappelle LJ; Koudstaal PJ
Cochrane Database Syst Rev; 2001; (4):CD001342. PubMed ID: 11687110
[TBL] [Abstract][Full Text] [Related]
37. [Preventing cerebrovascular accidents during atrial fibrillation].
Ederhy S; Meuleman C; Hammoudi N; Janower S; Boccara F; Cohen A
Presse Med; 2005 Oct; 34(18):1315-24. PubMed ID: 16269996
[TBL] [Abstract][Full Text] [Related]
38. Dabigatran and warfarin for secondary prevention of stroke in atrial fibrillation patients: a nationwide cohort study.
Larsen TB; Rasmussen LH; Gorst-Rasmussen A; Skjøth F; Lane DA; Lip GY
Am J Med; 2014 Dec; 127(12):1172-8.e5. PubMed ID: 25193361
[TBL] [Abstract][Full Text] [Related]
39. Preventing ischemic stroke in the older adult.
Ling GS; Ling SM
Cleve Clin J Med; 2005 Oct; 72 Suppl 3():S14-25. PubMed ID: 16265940
[TBL] [Abstract][Full Text] [Related]
40. Secondary prevention of atherothrombotic cerebrovascular events.
Paciaroni M
Curr Vasc Pharmacol; 2014 May; 12(3):365-72. PubMed ID: 24846225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
